Tickerplace logo

Tickerplace

Intensity Therapeutics, Inc. logo

INTSIntensity Therapeutics, Inc.

INTS Stock Price, Valuation & Chart | Intensity Therapeutics, Inc.

Compare
$4.000-0.07 (-1.72%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyINTS intrinsic valueINTS calculated fair value vs price
OverviewFinancialsDividendsRatios

INTS Historical price chart

INTS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization10.81M
PE Ratio-1.41
EPS-2.84
Trading Volume13.93K
Today's High/Low4.15/4.0
Dividend Yield0.00
52 Week High/Low43.5/3.51
Shares Outstanding2.70M
INTS Financial Statement
INTS Analyst ratings
INTS Analysis & performance metrics

INTS Company profile

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. The…

INTS Management team

Management
Joseph Talamo CPA, M.B.A.CFO
Chief Financial Officer
James M. Ahlers
Executive Vice President of Corporate Finance
John Wesolowski CPA, M.B.A.
Principal Accounting Officer & Controller
Brian Schwartz M.D.
Executive Vice President of Clinical Development
Lewis H. Bender M.A., M.B.A., M.S.CEO
Founder, President, Chief Executive Officer & Chairman of the Board
Total 5 executives

INTS Frequently asked questions

What is Intensity Therapeutics, Inc. (INTS) Stock Price?

Current stock price of Intensity Therapeutics, Inc. (INTS) stock is $4.000. The stock price is -1.72% lower in the session. The intraday range can be seen from this page. Volume of Intensity Therapeutics, Inc. (INTS) stock is 13.93K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Intensity Therapeutics, Inc. (INTS) stock price going up or down today?

The stock price of Intensity Therapeutics, Inc. (INTS) can change with earnings, company news, and overall market sentiment. Intensity Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Intensity Therapeutics, Inc. stock expensive at its current price?

Whether Intensity Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for INTS on this page is -1.41. EPS on this page is -2.84. Compare those figures with peers and growth expectations before deciding if the current Intensity Therapeutics, Inc. price is justified.

How has the stock price of Intensity Therapeutics, Inc. (INTS) performed historically?

Historical performance for Intensity Therapeutics, Inc. (INTS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how INTS reacted to past earnings and market events.

Should I buy Intensity Therapeutics, Inc. (INTS) stock, at this price?

Buying Intensity Therapeutics, Inc. (INTS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.